Clin2
NCT06443489Possibly a fitRecruiting

SHR-4849 for advanced solid tumors

Advanced Solid Tumors

Part of Cancer clinical trials.

This trial tests a new drug called SHR-4849 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and effective, and may offer a new option for those who have limited choices.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
80 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 18 and 75 years old
  • You have a type of advanced solid tumor that has spread or cannot be removed by surgery
  • You have at least one tumor that can be measured on a scan (like a CT or MRI)
  • You are able to take care of yourself and perform light activities (ECOG 0 or 1)
  • Your cancer has not spread to your brain in a way that is causing symptoms, and you do not have a serious heart condition

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06906731Not yet recruiting· Phase 1/Phase 2
Study of SHR-9803 for advanced solid tumors

This study tests an investigational drug called SHR-9803 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective in shrinking or slowing the growth of tumors.

Harbin, Heilongjiang
NCT06618651Recruiting· Phase 1
Study of SHR-3821 for advanced solid tumor cancers

This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.

Chengdu, Sichuan
NCT06907628Recruiting· Phase 1
Testing SHR-3792 for advanced solid tumors

This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.

Jinan, Shandong
NCT06474455Recruiting· Phase 1/Phase 2
Study of SHR-9839 with other treatments for advanced solid tumors

This trial tests a new drug called SHR-9839 combined with other cancer treatments for people with advanced solid tumors, including a certain type of lung cancer. The goal is to see if the combination is safe and effective against the cancer.

Zhengzhou, Henan
NCT06094556Recruiting· Phase 1
A study of SHR-1826 for advanced solid tumors

This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.

Guangzhou, Guangdong
NCT06605222Recruiting· Phase 1/Phase 2
Testing SHR-7787 for advanced solid tumors

This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.

Shanghai, Shanghai Municipality

Hear when a new Advanced Solid Tumors trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.